Glucose Monitoring Devices Market Growth, Size, Share, Trends, Key Players Analysis, and Forecast till 2030

Glucose Monitoring Devices Market Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Continuous Glucose Monitoring Devices, Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), End User (Healthcare Settings and Self/Homecare), and Geography

  • Report Code : TIPRE00004116
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 205
Buy Now

Glucose Monitoring Devices Market Size by 2030

Buy Now

The glucose monitoring devices market size is expected to grow from US$ 16,803.63 million in 2022 to US$ 39,530.75 million by 2030; it is estimated to register a CAGR of 11.3% from 2022 to 2030. Rapid Technological advancements in glucose monitoring devices will likely remain a key trend in the market.

Glucose Monitoring Devices Market Analysis

The primary factors propelling the market development are the growing geriatric population, rising incidence of diabetes, rising global prevalence of obesity, and the increasing number of product innovations. Moreover, products with cutting-edge technology provide better results when treating diabetes. Globally, the prevalence of diabetes is rising, which drives up demand for more advanced products. Thus, every year, new products are being developed as a result of research studies carried out by researchers.

Due to improvements in glucose monitoring technology, smaller blood volumes are needed for better accuracy. Additionally, glucose monitoring devices and blood glucose meters have better data transfer capability. Technological developments in blood glucose monitoring have increased accuracy, decreased blood volume requirements, and data transfer between glucose monitoring devices and blood glucose meters. For instance, Abbott unveiled a new wearable in June 2022 that uses a single sensor to monitor ketone and glucose levels continuously.

Glucose Monitoring Devices Market Overview

Sedentary lifestyles, poor diets, and obesity are the leading causes of obesity and diabetes cases. According to research published in the Journal of the American Heart Association, 30–53% of newly diagnosed cases of diabetes in the US each year are related to obesity. Obesity's effects raise the expense of medical care for prescription medications, inpatient care, and outpatient care. In the US, obesity-related medical expenses come to approximately US$ 260.6 billion a year. Thus, it is anticipated that there will be a greater need for glucose monitoring equipment in the upcoming years.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Glucose Monitoring Devices Market: Strategic Insights

Glucose Monitoring Devices Market

  • CAGR (2022 - 2030)
    11.3%
  • Market Size 2022
    US$ 16,803.63 Million
  • Market Size 2030
    US$ 39,530.75 Million

Market Dynamics

GROWTH DRIVERS
  • Increase in The Prevalence of Diabetes in emerging economies to boost the market growth
FUTURE TRENDS
  • Emergence of integrated devices with efficient connectivity solutions to offer lucrative opportunities in the market
OPPORTUNITIES
  • The Growing Demand for Glucose Monitoring Devices to propel the uptake

Key Players

  • B. Braun SE
  • LifeScan Inc
  • Abbott Laboratories
  • Medtronic Plc
  • Ypsomed Holding AG
  • Ascensia Diabetes Care Holdings AG
  • Nipro Corp
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare Technologies Inc

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Type
  • Continuous Glucose Monitoring Devices
  • Self-Glucose Monitoring Devices
Application
  • Type 1 Diabetes
  • Type 2 Diabetes
Testing Type
  • Fingertip Testing and Alternate Site Testing
End User
  • Healthcare Settings and Self/Homecare
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Glucose Monitoring Devices Market Drivers and Opportunities

An increase in the Prevalence of Diabetes Favors Market Growth

Diabetes is a chronic illness that poses a severe risk to life. The primary cause of it is the body's incapacity to make or use the hormone insulin. This incapacity hinders the body's ability to control blood glucose levels appropriately. Diabetes comes in two varieties: diabetes type ll, commonly referred to as diabetes insipidus, and diabetes type l. Globally, both the incidence and prevalence of diabetes are continuously rising. The most common type of diabetes, type 2, has grown in frequency in tandem with societal and cultural shifts. Up to 91% of adults with type 2 diabetes have the illness in high-income nations. By 2045, there will likely be 738 million diabetics worldwide, up from an estimated 537 million in 2021, as per the International Diabetes Federation (IDF).  Patients who have diabetes require frequent monitoring and external administration of insulin. The rising prevalence of diabetes globally is driving the growth of the glucose monitoring devices market

Significant Opportunities in Developing Regions

The governments of the Asia-Pacific region are concentrating on developing the medical tourism industry to increase revenue flow. By signing two strategic Memorandums of Understanding with well-known medical tourism and healthcare facilitators, Passage Asia and Ezy Healthcare, in May 2023, the Malaysia Healthcare Travel Council (MHTC) increased its global footprint and improved its seamless healthcare experience. A significant step forward in MHTC's mission to offer the most remarkable healthcare travel experience and expand into the Oceania region has been reached with these collaborations.

Additionally, in response to the pandemic, Abbott debuted a do-it-yourself version of its continuous glucose monitoring device in India in November 2020. For US$ 66.61, the reader is a one-time expense for the user, whereas the sensor may require replacement every three months for US$ 60.55. The sensor maps the sugar levels against factors like diet, exercise, and other factors over three months. It provides continuous readings for 14 days. The expanding Indian market presents prospects for foreign enterprises to enhance their earnings because of the nation's improving healthcare infrastructure.

Glucose Monitoring Devices Market Report Segmentation Analysis

Key segments that contributed to the derivation of the glucose monitoring devices market analysis are type, application, and end user.

  • Based on type, the glucose monitoring devices market is divided into continuous glucose monitoring devices, self-glucose monitoring devices. The self-glucose monitoring devices segment held the most significant market share in 2022.
  • By application, the market is categorized into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held the largest share of the market in 2022.
  • Based on testing type, the glucose monitoring devices market is divided into fingertip testing, alternate site testing. The fingertip testing segment held the most significant market share in 2022.
  • By end user, the market is segmented into healthcare settings and self/homecare. The self/homecare segment held the largest share of the market in 2022.

Glucose Monitoring Devices Market Share Analysis by Geography

The geographic scope of the glucose monitoring devices market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

The US, Canada, and Mexico comprise the three segments of the North American market for glucose monitoring devices. This region's market is growing because of the rising prevalence of diabetes and an aging population, which are the main factors driving the market's growth. Furthermore, technological advancements in monitoring devices further enhance the overall market growth. In the US alone, over 37 million children and adults have diabetes, according to a report by the American Diabetes Association. An estimated US$ 16,752 is spent on diagnosed diabetes each year in the US, of which US$ 9,601 is directly related to the disease.

Additionally, the United States spends a lot of money on hospital inpatient care (30% of total medical costs), prescription drugs to treat diabetes complications (30%), anti-diabetic drugs and diabetes supplies (15%), and doctor visits (13%). Thus, diabetes is so common in the US and costs so much to treat that the US population is adopting glucose monitoring devices faster, driving the market's growth.

Glucose Monitoring Devices Market Report Scope

Report Attribute Details
Market size in 2022 US$ 16,803.63 Million
Market Size by 2030 US$ 39,530.75 Million
Global CAGR (2022 - 2030) 11.3%
Historical Data 2020-2021
Forecast period 2022-2030
Segments Covered By Type
  • Continuous Glucose Monitoring Devices
  • Self-Glucose Monitoring Devices
By Application
  • Type 1 Diabetes
  • Type 2 Diabetes
By Testing Type
  • Fingertip Testing and Alternate Site Testing
By End User
  • Healthcare Settings and Self/Homecare
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • B. Braun SE
  • LifeScan Inc
  • Abbott Laboratories
  • Medtronic Plc
  • Ypsomed Holding AG
  • Ascensia Diabetes Care Holdings AG
  • Nipro Corp
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare Technologies Inc
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Glucose Monitoring Devices Market News and Recent Developments

    The glucose monitoring devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the glucose monitoring devices market are listed below:

    • Beurer India Pvt. Ltd, manufacturer of electric healthtech devices, has announced the launch of a blood glucose monitor device retailing for ₹1,200, which will be available in the market by September 2024. (Source: Beurer India Pvt. Ltd, News Latter, May 2024)
    • Dexcom, a real-time continuous glucose monitoring (CGM) device manufacturer for people with diabetes, has launched its latest CGM system, Dexcom ONE+ in Ireland. Dexcom ONE+ uses Dexcom’s best-in-class and most accurate sensor design. (Source: Dexcom, News Latter, March 2024)

    Glucose Monitoring Devices Market Report Coverage and Deliverables

    The “Glucose Monitoring Devices Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

    • Glucose monitoring devices market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Glucose monitoring devices market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Glucose monitoring devices market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the glucose monitoring devices market
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Type, Application, Testing Type, End User, and Geography

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What is the expected CAGR of the glucose monitoring devices market?

    The market is expected to register a CAGR of 11.30% from 2023 to 2031.

    Which are the leading players operating in the glucose monitoring devices market?

    B. Braun SE, LifeScan Inc, Abbott Laboratories, Medtronic Plc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, Nipro Corp, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc, Senseonics Holdings Inc., Terumo Corp

    What are the driving factors impacting the glucose monitoring devices market?

    Key factors driving the market are the increase in the prevalence of diabetes and the growing demand for glucose monitoring devices.

    What are the future trends of the glucose monitoring devices market?

    Technological advancements in glucose monitoring devices will likely remain a key trend in the market.

    Which region dominated the glucose monitoring devices market in 2023?

    North America dominated the glucose monitoring devices market in 2023

    Trends and growth analysis reports related to Medical Device : READ MORE..